Industry in brief | Karo, Probi, Enzymatica
23 July 2021
Karo Pharma, Probi and Enzymatica have released financial results.
Industry News - Tag: Enzymatica
You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
Stada and Enzymatica add Vietnam to partnership
Premium
13 July 2021
Stada has inlicensed exclusive rights to Enzymatica’s ViruProtect in Vietnam and plans to launch the common cold spray in the country in 2022.
Enzymatica promotes Egstrand to chief executive
Premium
13 July 2021
Enzymatica – the Swedish company behind the ColdZyme common cold spray – has promoted Claus Egstrand to chief executive officer.
People in brief | Enzymatica, EFPIA, The Emerson Group
22 June 2021
Enzymatica has recruited two people, the European Federation of Pharmaceutical Industries and Associations (EFPIA) has appointed a new presidency team, and the US Consumer Healthcare Products Association (CHPA) has honoured a longtime industry leader.
Enzymatica sells ColdZyme on Amazon in UK and Sweden
Premium
7 June 2021
Enzymatica has started selling its ColdZyme common cold spray on Amazon in Sweden and the UK.
Enzymatica issues warning and plans fundraising
Premium
29 March 2021
Enzymatica has warned that sales of its ColdZyme common cold spray may be lower in 2021 than in 2020 due to the impact of the COVID-19 pandemic.
People in brief | McKesson, Enzymatica, CRN
19 January 2021
McKesson Europe has a new chief financial officer, Sweden’s Enzymatica has made changes to its management team, and the US Council for Responsible Nutrition (CRN) has a new chair.
Stada and Enzymatica add Nordics to partnership
9 December 2020
Germany’s Stada has inlicensed rights to Enzymatica’s ViruProtect common cold spray in the Nordic region excluding Sweden.
MS Pharma and Enzymatica agree ColdZyme deal in MENA
Premium
16 November 2020
MS Pharma is set to launch Enzymatica’s common cold spray, ColdZyme, under its registered trademarks in the Middle East and North Africa (MENA).
Sanofi strikes deal for ColdZyme in France and Italy
Premium
23 October 2020
Sanofi Consumer Healthcare is set to launch Enzymatica’s common cold spray, ColdZyme, under its established brands in France and Italy.